EUROMED ginkgo biloba extracts are standardized herbal extracs of Ginkgo biloba L. leaves, a “fossil tree” growing in Asia
and today widely cultivated as a medicinal plant in Korea, the southeast of France and the United States.
A multitude of polar and apolar compounds have been isolated in ginkgo biloba leaves: aliphatic alcohols and keatones, organic
acids, sesquiterpenes (bilobalide) and saccharides. Interesting compounds from the therapeutic point of view are flavonoids
compounds from the therapeutic point of view are flavonoids and diterpenes.
The flavonoids are represented by about twenty flavonol glycosides, quercetin and kaempferol 3-rhamnosides and quercetin and kaempferol, and by biflavonoids (amentoflavone, bilobetol, 5- mehoxybilobetol…). Ginkgo biloba leaves also have flavan-3-ols and proanthocyanidins. Ginkgo biloba diterpenes, known as ginkgolides A,B, C, J and M, have and hexacylic structure characterized by a spiro- [4,4]-nonanic sequence, a tert-butyl group, and three lactones rings.
Extracts of ginkgo biloba leaves are proposed to treat the symptons of senile cerebral insufficiency, memory loss associated with aging,
early stages of Alzheimer’s disease, poor circulation to the extremities, intermittent claudication, tinnitus and hearing loss.
Ginkgo biloba extracts have antoxidants activity and ability to inhibit platelet aggregation, wich are critical in the prevention of
Contraindications, interactions and side-effects
Ginkgo biloba extract is generally well tolerated, but it is contraindicated in patients known to be hypersensitive to ginkgo
biloba preparations. In less than 1 percent of patients mild gastrointestinal complaints may occur and patients with poor blood
flow may experience a mild, transient headache for the first and second days of use.
Due to the inhibitory effect on the platelet-activating factor (PAF) if could interact with antithrombotic therapies. Contraindications
to the use of ginkgo biloba extracs during pregnancy or lactation have not been reported.